SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " treat " 2,704 found 🔀 AI-powered Shuffle
Could a ‘digital twin’ help you get better health care?
Scientists are working to create "digital twins" of patients that they can test treatments on, in hopes of delivering personalized health care.
Reproductive health clinics scramble as Title X funding cliff approaches
Title X is a 56-year-old federal grant program that supports thousands of clinics that provide birth control and STI testing and treatment around the country. Now those clinics could face a funding gap because of a Trump administration delay.
Psychiatrists’ Use of Biomarkers Could Open a New Window Into Mental Health Diagnoses
The world’s largest professional psychiatry organization is preparing for the day when biological indicators can help diagnose and treat mental illness.
The scientist who warned that profit, not science, decides which drugs reach patients
In a Genomic Press Interview published in Brain Medicine, Dr. Gabriella Gobbi, Professor of Psychiatry at McGill University, Canada Research Chair (Tier 1) in Therapeutics for Mental Health, and President-Elect of the Collegium Internationale of Neuropsychopharmacology (CINP), delivers a pointed warning: the greatest threat to drug discovery is not scientific failure but a financing system that abandons effective, affordable treatments whenever they cannot promise sufficient returns to investors. Across a career that began in central Italy and moved through Sardinia and Montreal, Dr. Gobbi has generated landmark research linking adolescent cannabis exposure to depression, identified novel melatonin receptor mechanisms in sleep and pain, and launched psychedelic neuroscience before it became fashionable. The interview reveals a scientist whose best questions have always begun at the bedside, and whose most urgent fears concern the structures that stand between discovery and patients.
Cannabis is not an effective treatment for common mental health conditions, says review
International researchers find ‘very little evidence’ medical form of the drug can treat anxiety, anorexia and other disorders
Live Whole Health #309: Natural pain relief
Experts recommend non-drug methods of managing low back pain as a first line of treatment, and yoga is on the list of safe and effective ways to manage pain.
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness –CUE-401 is the Company’s lead asset for the treatment of autoimmune and inflammatory diseasesAppointed industry veteran Lucinda Warren as Chief Financial and Business OfficerRaised net proceeds of $10.2M through an underwritten public offeringAnnounced strategic collaboration and license agreement with ImmunoScape to develop breakthrough cell therapy approach for solid tumors – Entitled to receive upfront
New obesity statistics highlight importance of preventive cardiology
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
First case of severe mpox disease reported in major city: ‘Life-threatening’
First severe mpox clade I case identified in NYC resident who traveled abroad. Health officials say local transmission risk remains low for the community.
UPMC warns embattled data exchange Health Gorilla may have improperly pulled patient records
UPMC says its medical records may have been improperly accessed by Health Gorilla, a patient data gatekeeper accused in federal court of mismanaging sensitive information. Health Gorilla requested data “under the pretext of providing treatment to shared UPMC patients and claimed it had permission to do so,” according to a
State Announces Intent to Award $20 Million to Santa Barbara County for New Behavioral Health Residential Facilities in Santa Maria
Funding Through California’s Behavioral Health Continuum Infrastructure Program Will Support Two 16-bed Community Residential Treatment Facilities Focused on Diversion and Recovery
Susie Wiles, White House chief of staff, has breast cancer, Trump says
The president announced the White House chief of staff’s diagnosis Monday, saying she has a good prognosis and will continue to work while receiving treatment.
Partisanship and science
I recently participated in a symposium of the Denver-based Institute for Science & Policy, during which I had a “fireside chat” with Tony Mills of the American Enterprise Institute. Mills has written extensively on the politicization of science, and the two of us had a very enjoyable hour-long conversation on the topic. You can watch it below. The main questions we dealt with are why there is such a vast partisan gap in trust of science, and to what extent this is a unique moment. Mills helpfully brings a good deal of data to the discussion, as he did in this useful piece at Issues in Science & Technology. Tusk depends on reader support. To support this work, please become a paid subscriber. Subscribe Note this graph, drawing on a range of survey data to demonstrate partisan attitudes toward science since 1970s. As it demonstrates, there’s been a very sharp partisan divergence in confidence in science during the Trump Era, starting prior to the Covid pandemic. At least in part, we can attribute this to a rise in populist anti-science rhetoric embraced by Trump, his appointees, and those in his media orbit. But as the graph also shows, the partisan divide has existed in the past, and it’s not always in the same direction. The largest divergence in party views toward science prior to 2016 was in the 1970s, when liberals equated scientific achievement with the military-industrial complex and thus trusted it less. That era of scientific mistrust is often overlooked. Indeed, as Mills notes, the Moon landings (1969-72), which today are considered one of the last great moments of national unity, were experienced nothing like that at the time. There was sharp debate back then over whether the Apollo missions were worth the vast expenditures when the country had so much else to deal with. It’s outside the dataset, and we don’t have the partisanship lens for it, but the 1950s was another deeply anti-science decade, with critics of intellectuals and college professors alleging their ties to communism and their lack of commitment to basic American moral beliefs. This was the subject of Richard Hofstadter’s 1962 book Anti-Intellectualism in American Life, in which he quotes religious leaders like Franklin Graham: [In place of the Bible] we substituted reason, rationalism, mind culture, science worship, the working power of government, Freudianism, naturalism, humanism, behaviorism, positivism, materialism, and idealism. [This is the work of] so-called intellectuals. Thousands of these “intellectuals” have publicly stated that morality is relative—that there is no norm or absolute standard.… This fervor was heavily whipped up by Sen. Joe McCarthy (R-Wisconsin), although it’s clear that not all his fellow Republicans were on board with his red-baiting. What ended that era? The simple answer is the 1957 launch of Sputnik. Americans became afraid that they were losing to Soviet scientists, and suddenly university researchers and government projects were awash with funding. In our conversation, I asked Mills about the possibility of us having a Sputnik moment again that would rally the American public in favor of science today. Mills argued that the COVID-19 pandemic was essentially a Sputnik moment — a terrifying threat to all Americans that required scientific advances to address. But thanks in part to political polarization and the populist and conspiratorial leanings of Donald Trump, we got the opposite of a unifying moment. Many Americans turned against science, despite science actually stepping up in that moment. As we discussed in the chat, it’s not clear what scientists could or should be doing in this moment to increase faith in their work. As Mills notes, one of the chief complaints against scientists and professors is that they’ve become too political; scholars becoming even more political might not help them achieve their goals. This (mainly Republican-driven) anti-science era will end, of course, but it’s not clear what event will bring that about. Share
Op-Ed: Sherrill's misguided retreat on smart business tax policy
Fifteen years ago, Republicans and Democrats agreed to make New Jersey more competitive. Now, the governor wants to push us backward
Dartmouth Health to open new addiction treatment center in Claremont
Dartmouth Health opens an outpatient addiction treatment center at Valley Regional Hospital in Claremont, providing convenient and timely care.
As mental health crisis grows, legal skirmish around treatment persists in Orange County
Even if a lawsuit between the county and the nonprofit that runs Be We OC ended today, the county would still struggle to treat about 40,000 indigent residents who suffer extreme mental illness.
Is stem cell therapy the next frontier to treat diabetes? Louisiana experts aren't convinced.
Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from Louisiana experts. "Maybe in 20 years," a doctor at LSU Health says. Here's what to know now.
Thousands of people disabled by long COVID seek answers
Six years after the COVID-19 pandemic began, doctors are still treating long COVID patients with complex symptoms and unknown futures.
Intermountain Health employee pleads guilty after stealing 100+ prescriptions from Colorado patients
A former employee of Intermountain Health in Colorado has pleaded guilty after she stole more than 100 prescriptions from patients being treated for significant pain.
Textbooks were wrong: Scientists reveal the surprising way human hair really grows
Hair may grow in a completely different way than scientists once believed. Instead of being pushed out from the root, new research shows that moving cells inside the follicle actually pull the hair upward like a microscopic motor. Advanced 3D imaging revealed a spiral movement of cells that generates this force. The finding could change how scientists study hair loss and design future treatments.
This doctor treated migrants’ severe injuries at the US-Mexico wall: ‘Political decisions made it as violent as possible’
Dr Brian Elmore witnessed a public health crisis unfold at the border near El Paso. He reflects on why it was like a ‘perverse Groundhog Day’
Pasqual's in Verona closing, Easter treats, and a new NBA record
The Cap Times' new Food & Culture newsletter shares Madison area restaurant news, with recommendations for what to read, watch, listen and eat.
America has health alarm fatigue. I know because I treat it
“We cannot let alarm fatigue silence the response to Kennedy’s and Trump’s destruction,” writes Robert Shpiner.
How Golden Entertainment (GDEN) Narrative Is Shifting As Analysts Reassess Risk And Reward
Golden Entertainment’s latest analyst update keeps the fair value target steady at $30.50, even as assumptions behind that figure shift. Bullish and bearish voices are now reading the same unchanged headline number in very different ways, with some seeing headroom for upside and others treating it as a signal that the risk or reward balance has cooled. As you read on, you will see how these views are forming and how you can track the story as it continues to evolve. Analyst Price Targets...
A major change could be coming in mental health diagnoses, psychiatrists say
The world’s largest professional psychiatry organization is preparing for the day when biological indicators help diagnose and treat mental illness.
Woman tests how Home Depot workers treat her in a “hot girl” outfit vs dressed “like a boy”
Does pretty privilege apply at the hardware store?
Depression may start with an energy problem in brain cells
Researchers have discovered a surprising change in how cells produce energy in people with depression. Brain and blood cells in young adults with major depressive disorder produced more energy molecules at rest but had trouble increasing energy production when needed. Scientists believe this imbalance may contribute to symptoms such as fatigue and low motivation. The finding could help pave the way for earlier diagnosis and more personalized treatments.
Breakthrough to Strengthen Bones Could Reverse Osteoporosis
A potential treatment for millions.
Republicans Concede They Need a Pivot on Immigration Ahead of Midterms
In public comments and private meetings at a House G.O.P. retreat, top officials allowed that President Trump’s immigration crackdown had hurt the party and that they needed a course correction on the issue.
Health Care Roundup: Market Talk
Gain insight on eczema treatments, Roche Holding’s recent pipeline updates and more in the latest Market Talks covering the health care sector.
Healthcare Uses Specialized Language. It Needs Specialized AI, Too.
The potential generative AI in healthcare is enormous. They can generate patient education materials or clinical notes in seconds, flag incomplete documentation to keep care on track, or even suggest differential diagnoses . But when generalist models encounter the specialized “dialects” used across medical fields, they can miss critical clinical meaning—even when they read every word correctly. The result can be flawed decisions and eroding clinician trust. Healthcare organizations should treat AI like a supervised trainee: adapt models to clinical specialties, require transparent reasoning, and calibrate automation with human oversight.
Federal officials walked back claims on leucovorin. Here’s what families should know now
The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they feel abandoned by the US Food and Drug Administration’s new stance on leucovorin.
How to Solve One of the Most Expensive Problems in Employer Healthcare
A small share of employees drives a disproportionate share of employer health-care spending: They are patients whose complex conditions go undiagnosed as they cycle through a fragmented care system. A diagnostic-focused “center of excellence” model—such as the Mayo Clinic Complex Care Program—offers a different approach: coordinated, multidisciplinary evaluations that identify the right diagnosis quickly. Evidence from employer claims shows that earlier, accurate diagnoses can improve outcomes, reduce unnecessary procedures, and lower costs by shifting care from repeated testing toward targeted treatment.
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027BURLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business updates and reported financial results for the fourth quarter and year ended Decembe
Oil prices retreat, Asian shares rise after report of planned IEA oil reserve release
International Energy Agency reportedly proposed argest release of oil reserves in its history to bring down crude prices
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
$250,000 top award goes to Connor Hill in America’s longest running and most distinguished science and math competition Top $250,000 Regeneron Science Talent Search Winner Named Regeneron and Society for Science announced that Connor Hill, 17, of State College, Pennsylvania, won the top award of $250,000 in the 2026 Regeneron Science Talent Search (STS), a program of Society for Science. TARRYTOWN, N.Y. and WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. and Societ
FDA declines to endorse leucovorin for autism, walking back earlier statements suggesting benefit
The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when officials touted the drug as a potential treatment for thousands of children with autism.
Scientists discover molecule that stops aggressive breast cancer in its tracks
Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease. The compound, called SU212, targets and disables a key enzyme that cancer cells rely on to fuel their growth. In tests using humanized mouse models, the molecule caused tumors to shrink and slowed the spread of cancer by forcing the enzyme to break down.
Cancer Haunts Neighbors of Canada’s Oil Sands Wastelands
Though high rates of the disease persist among the nearby Indigenous communities, the Canadian government is weighing rules that may allow energy giants to release treated mining waste into the river system.
Cannabis compounds could reverse disease affecting one-third of adults
Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.
Trump Threatens to Crowd Out Republicans’ Midterm Message
As the G.O.P. gathered in Miami for a party retreat where lawmakers hoped to focus on the economy, the president was threatening to block his own party’s legislative agenda.
trawberry Festival draws crowds, sweet treats, entertainment
It was a “berry” sweet weekend at Floral Park in Floral City as tens of hundreds of people packed into the park for the 39th Floral City Strawberry Festival Saturday
Hims & Hers Announces Strategic Shift for US Weight Loss Business
Starting with a new collaboration with Novo Nordisk, the company announced plans to align its US and global strategies with a focus on an increasing variety of FDA-approved GLP-1s Hims Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evolving its US offering to match the company’s approach globally. In the US, the company now plans to provide GLP-1 customers with access to a broad assortment of FDA-approved medications and offer compounded semaglutide through the platform on a limited scale. By aligning its domestic and international models in weight loss, Hims Hers will become the largest global consumer health platform for access to more affordable, approved medications. The US weight loss landscape has transformed dramatically since Hims Hers entered the market in 2023. Progress in the industry has made a broader range of FDA-approved GLP-1 treatments
$106M 'mental health village' in Norwalk breaks ground: What to know
LA County has officially broken ground on a first-of-its-kind "Care Community" at the Metropolitan State Hospital campus, turning vacant buildings into 162 beds of treatment and housing.
Seattle clinic gets homeless youth engaged in care by treating their pets
A clinic at the New Horizons Youth Shelter treats young people alongside their pets to build better relationships with the medical system — with promising results.
San Antonio archbishop: Profit, politics play roles in inhumane migrant treatment
"These detention centers … cannot have empty beds, because otherwise they don't make money," said Archbishop Gustavo García-Siller. "It's business, business, business, business, business."
Letters to the Editor: A free market inherently doesn’t work when it comes to healthcare
'Providers are required by law to treat patients, and sick or injured people are hardly in a position to walk away if the treatment is a little more costly than they would like,' writes an L.A. Times reader.
Scientists discover protein that triggers diabetic blindness
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the earliest damage in diabetic retinopathy by constricting tiny retinal blood vessels and reducing oxygen supply. In mice, shutting down this protein stopped the damage before it could take hold. The finding could pave the way for treatments that protect vision before symptoms ever begin.
Controversial top vaccine regulator to depart FDA
Vinay Prasad, the top regulator overseeing vaccines and complex treatments for difficult diseases, had previously lost his job in July before getting it back less than two weeks later.
SAMHSA Announces More Than $69 Million in Funding Opportunities for Serious Mental Illness and Suicide Prevention Grant Programs
SAMHSA announced $69.1 million in funding for: the Children's Mental Health Initiative (CMHI), Zero Suicide, and Assisted Outpatient Treatment (AOT).
L.A. County transforms vacant buildings into ‘mental health treatment village’
Los Angeles County leaders are breaking ground Friday on a new mental health treatment complex that will transform long-vacant buildings on a historic Norwalk hospital campus into a “village” for c…
Bringing advanced neurological care to South Texas families - UT Health San Antonio
“We’re not only treating conditions — we’re caring for people across the full spectrum of brain health. When someone hears the words, “You have ALS,” or “This may be dementia,” life changes instantly. Questions come faster than answers, appointments multiply and the future feels uncertain. For patients and families navigating that uncertainty, UT Health San […]
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2025 fiscal year ended December 31, 2025. Key Highlights: Regulatory Progress: Achieved positive clinical study results from the AD04-103 pharmacokinetics (P
Friday briefing: Can the politics of cruelty around asylum help Labour in the polls?
In today’s newsletter: Labour’s new asylum framework marks a decisive shift in how the UK treats people granted protection and exposes tensions between electoral strategy, public service pressures and the party’s historic commitments to human rights
San Antonio archbishop: Profit, politics play roles in inhumane migrant treatment
(OSV News) — Days after a meeting among several Catholic bishops serving along both sides of the Texas-Mexico border — a regular gathering for the “Tex-Mex” bishops — OSV News spoke…
Tylenol orders for some pregnant women fell after Trump said to avoid it
New research found that Tylenol orders fell for pregnant women who visited the E.R. in the months after Trump’s statements. Prescriptions rose, meanwhile, for leucovorin, a drug the administration touted as a potential autism treatment.
How does hair loss differ between men and women?
Learn how men’s and women’s hair loss is treated differently and what you can do to prevent it.
Patient health data as a public utility: A former ARPA-H data chief explains
Patients generate vast health data, but private companies monetize it. A policy group proposes treating the data like a regulated utility.
Brain Tech Startup Science Corp. Raises $230 Million to Treat Blindness
Neurotechnology company Science Corp. raised $230 million from investors to commercialize its implant for blindness and develop even more advanced brain devices.
Six federal scientists run out by Trump talk about the work left undone
Federal data shows the NIH lost about 4,400 people — more than 20% of its workforce. Scientists say the departures harm the U.S.’ ability to respond to disease outbreaks, develop treatments for chronic illnesses, and confront the nation’s most pressing public health problems.
Slowing Huntington’s disease: how science advice enabled a breakthrough treatment
A coordinated research effort shows how science advice and shared infrastructure can help turn new ideas into meaningful progress for people and communities.
1,473 injured since Saturday: Health Ministry summarizes first days of Operation Roaring Lion
As of 7 a.m. on March 5, 2026, 145 people remain hospitalized or are currently being treated in emergency departments, the ministry said.
Scientists discover the protein that malaria parasites can’t live without
Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a traffic controller during the parasite’s unusual cell division process, ensuring its genetic material is properly separated as it multiplies. When scientists switched off ARK1 in laboratory experiments, the parasite could no longer replicate correctly and failed to complete its life cycle in both humans and mosquitoes—effectively halting its ability to spread.
Millions with joint pain and osteoarthritis are missing the most powerful treatment
Stiff knees and aching hips may seem like an inevitable part of aging, but experts say we’re getting osteoarthritis all wrong. Despite affecting nearly 600 million people worldwide — and potentially a billion by 2050 — the most powerful treatment isn’t surgery or medication. It’s exercise. Movement nourishes cartilage, strengthens muscles, reduces inflammation, and even reshapes the biological processes driving joint damage.
Bipartisan bill requiring annual mental health screenings by Oklahoma providers advances
The policy seeks to help detect symptoms early and connect patients to care before their mental health condition worsens and treatment becomes more costly.
Sony Reportedly Retreating From PlayStation's PC Platform Push
Sony is reportedly going back to console exclusives.
'In a bit of chaos': FDA watchers warn about agency hemorrhaging staff and the risk to America's health
Scientific, political pressures colliding at FDA, delaying rare disease treatment for patients who have few or no options, experts said at CNBC Cures Summit.
Phillies' Johan Rojas facing suspension for violating drug program
Johan Rojas is facing an 80-game suspension after violating Major League Baseball’s Joint Drug Prevention and Treatment Program.
Letitia James demands NYU Langone resume transgender treatment for kids after hospital axes program
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and durable treatment than the current standard of care for patients with wet AMD, DME and RVO Visara, a NovaBridge Majority-Owned Subsidiary, Holds Global Rights to VIS-101 Outside of Greater China and Certain Asian Territories ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform co
Linus Health to Present New Findings on Digital Risk Scores for Dementia and Patient-Centered Endpoints at Leading Global Alzheimer's and Parkinson's Conference
Linus Health will present new research at a leading global Alzheimer's and Parkinson's Diseases conference, revealing how advanced insights from digital cognitive assessments and personalized outcome measures may help transform how patients are identified for emerging therapies and how treatment impact is measured in ways that reflect patients' personal priorities.
Metformin treated diabetes for 60 years. Now scientists find it works in the brain too - Futura-Sciences
Doctors have prescribed metformin for type 2 diabetes since the 1950s. It works: reliably, cheaply, and with a safety record few drugs can match. What nobody fully understood, until now, was how. A study published in Science Advances on July 30, 2025, by researchers at Baylor College of Medicine and...
Common Arthritis Drug Found To Lower Blood Pressure and Boost Heart Health
A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability to calm an overactive immune system and reduce painful joint inflammation. Now, researchers say it m
Scientists just found the brain’s hidden defense against Alzheimer’s
A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments.
Scientists find the genetic switch that makes pancreatic cancer resist chemotherapy
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more structured and treatable form—but it gets shut down by an overactive KRAS-driven pathway. When researchers blocked that pathway, GATA6 levels rebounded and cancer cells became more sensitive to chemo. The discovery could help turn some of the toughest pancreatic tumours into ones doctors can better control.
World Birth Defects Day: “Behind every diagnosis is a story that deserves to be supported through strong public policies and strengthened health systems”
Interview with Pablo Durán, Regional Advisor on Perinatal and Neonatal Health at PAHOWashington, D.C., March 3, 2026 (PAHO) – Today marks World Birth Defects Day, an opportunity to raise awareness about a group of conditions that remain one of the leading causes of neonatal mortality and childhood disability in the Region of the Americas. Although many can be prevented or treated, thousands of families each year face diagnoses that require specialized care, continuous follow-up, and comprehensive support.
Actor Bruce Campbell announces cancer diagnosis
Star of The Evil Dead franchise Bruce Campbell announced Monday that he is battling a “treatable” but “not curable” form of cancer. Campbell did not reveal the type of cancer he is battling, but sa…
House unanimously passes bill to improve access to subacute mental health care
The bill, aimed at making nonemergency in-patient mental health care treatment programs more accessible, passed the House unanimously.
BBC Audio | Business Daily | The worldwide weight-loss revolution
Drugs like Ozempic, Wegovy, Mounjaro and Zepbound are reshaping global obesity treatment
What Is Trump’s Neck Rash? His Doctor Declines to Explain.
President Trump’s physician did not explain what the skin condition was or what medication he was using to treat it.
What Is Trump’s Neck Rash? His Doctor Declines to Explain.
President Trump’s physician did not explain what the skin condition was or what medication he was using to treat it.
Trump’s neck rash is because of ‘preventative skin treatment,’ his doctor says
A new rash on the right side of President Donald Trump’s neck is the result of a cream that he’s using as a “preventative skin treatment,” his personal physician told CNN on Monday.
States Move to Limit Access to H.I.V. Treatment
Citing shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.
Health Ministry says 960 people have been treated at hospitals since start of Iran fighting
* * *
UCLA Health Receives $100M for Mental Health Treatment
UCLA Health has received the largest single gift in its history devoted to mental health care: $100 million to expand mental and behavioral health services at the health campus, in part by supporting construction of a new neuropsychiatric hospital.
As Trump urges GOP to retreat from anti-vax rhetoric, DeSantis doubles down on exemption bill amid rising measles cases
Florida advances exemptions as national GOP moderates vaccine tone
Doctor says he turns adopted daughter's health around with a novel means of treatment
New Toothpaste Stops Gum Disease Without Harming Healthy Bacteria
Researchers have developed a targeted approach to combat periodontitis without disrupting the natural balance of the oral microbiome. The innovation could reshape how gum disease is treated while preserving beneficial bacteria.
After federal retreat, Twin Cities’ stores and restaurants piecing businesses back together
Some restaurants in immigrant corridors are back to a full menu; others have reopened for a few days a week, and some businesses might consolidate some locations.
Opinion | Mental health care can't replace the gun bills we don't pass
"The Republican proposals — crisis hotlines, treatment beds, mobile crisis units," Edward F. Kouneski writes, "Every one of them responds to a problem that has already emerged."
Is Greenland’s health system as bad as Donald Trump says it is?
Greenland’s government has reiterated the need for foreign healthcare staff and the strengthening of its health system following a US statement alleging patients are not properly treated in the country.
Scientists discover microbe that breaks a fundamental rule of the genetic code
Scientists at UC Berkeley have discovered a microbe that bends one of biology’s most sacred rules. Instead of treating a specific three-letter DNA code as a clear “stop” signal, this methane-producing archaeon sometimes reads it as a green light—adding an unusual amino acid and continuing to build the protein. The result is a kind of genetic coin flip: two different proteins can emerge from the same code, influenced partly by environmental conditions.
Kansas’ new ID law could have health consequences for trans people
Happy Friday. If I ever have kids, I want them to be treated at the newly christened Dolly Parton Children's Hospital in Tennessee. What’s your favorite
Governor Hochul Launches Public Awareness Campaign to Educate New Yorkers on Access to Behavioral Health Treatment
Governor Kathy Hochul today announced the launch of a public awareness campaign to educate New Yorkers on regulations that improve access to mental health and substance use disorder care. The ‘Real Care, Real Access to Behavioral Health Services’ campaign highlights regulations that give New Yorkers with qualifying health plans access to initial outpatient appointments for behavioral health care within ten business days of the request and require insurers to help insured individuals access the care they are entitled to receive.
This plant's been called 'nature's Valium' — it can help fight anxiety, reduce stress and treat insomnia
Serial burglar steals from family-owned business in Bellaire for kids on the spectrum
Any kid would love to spend time at We Rock the Spectrum, a kid's gym in Bellaire specifically designed for sensory play and kids on the spectrum. But there's a repeat uninvited visitor that's stealing cash and even treats meant for kids.
American heart health worsening
New statistical snapshot finds disappointing trend despite advances in treatment, ways to prevent nation’s leading cause of death.